The therapeutic implications of the hypothesis of allergic hypersensitivity as dysfunction of the intracellular immune mechanism.
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000328:Adult; D000707:Anaphylaxis; D000728:Androgens / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002648:Child; D003920:Diabetes Mellitus / Q000209:etiology; D004032:Diet; D005938:Glucocorticoids / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D006967:Hypersensitivity / Q000628:therapy*; D006968:Hypersensitivity, Delayed; D007109:Immunity; D010447:Peptide Hydrolases / Q000627:therapeutic use; D012774:Shock, Traumatic / Q000209:etiology; D012852:Sinusitis / Q000188:drug therapy / Q000601:surgery; D012882:Skin Tests; D013566:Sympathomimetics / Q000627:therapeutic use; D013963:Thyroid Hormones / Q000627:therapeutic use; D014456:Ulcer / Q000209:etiology; D014970:Xanthines / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000728:Androgens; D001993:Bronchodilator Agents; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists; D013566:Sympathomimetics; D013963:Thyroid Hormones; D014970:Xanthines; D010447:Peptide Hydrolases